Marsico Capital Management’s Juno Therapeutics, Inc. JUNO Stock Holding History

Marsico Capital Management’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-133,979	Closed	-$5.45M	–	104
2015 Q3	$5.45M	Buy	133,979 +28,545	+27%	+$1.25M	0.06%	81
2015 Q2	$5.62M	Sell	105,434 -120,868	-53%	-$6.42M	0.05%	84
2015 Q1	$13.7M	Buy	226,302 +51,235	+29%	+$2.49M	0.12%	76
2014 Q4	$9.14M	Buy	+175,067	New	+$7.83M	0.07%	75

Other funds holding JUNO

Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

BCM

Biomark Capital Management Greenwich, Connecticut $8.9M AUM 97.06% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Marsico Capital Management's JUNO Position: Q4 2015 in Review

Marsico Capital Management sold out of Juno Therapeutics, Inc. (JUNO) in Q4 2015, closing a stake of 133,979 shares — an estimated $5.45M sold.

Marsico Capital Management first reported a position in JUNO in Q4 2014 and held it in 4 quarters. The position peaked at $13.7M in Q1 2015. 160 funds tracked by Wall St. Rank hold JUNO as of Q4 2015.

Marsico Capital Management reported no remaining Juno Therapeutics, Inc. position as of Q4 2015 after selling out during the quarter.
Marsico Capital Management sold 133,979 Juno Therapeutics, Inc. shares in Q4 2015, an estimated $5.45M.
Marsico Capital Management first reported a position in Juno Therapeutics, Inc. in Q4 2014 and held it in 4 quarters.
Marsico Capital Management's Juno Therapeutics, Inc. position peaked at $13.7M in Q1 2015.
160 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q4 2015.

Based on Marsico Capital Management's 13F filing for Q4 2015, filed 12 Feb 2016.